Clinical use of DNA recombinant human growth hormone
https://doi.org/10.14341/probl11996
Abstract
The article is devoted to the issue of the clinical use of DNA recombinant human growth hormone.
References
1. Amselem S. et al. // International Symposium on Growth and Growth Disorders, 11-th.- Stockholm, 1991.- P. 81-86.
2. Christiansen J. S., Jorgensen J. 0. L. // Acta endocr. (Kbh.).- 1991.- Vol. 125.- P. 7-13.
3. Hirschberg R., Rabb H., Bergamo R., Kopple J. D. // Kidney int.- 1989.- Vol. 35.- P. 865-870.
4. Ibrahim Z. H. Z., Matson P. L., Buck P., Lieberman B. A. // Fertil. and Steril.- 1991.- Vol. 55, N 1.- P. 202-204.
5. Kopple J. D., Hirschberg R. // Miner. Electrolyte Metab.- 1990.- Vol. 16.- P. 82-88.
6. Lanzone A., Simone N. D., Castellani R. et al. // Fertil. and Steril.- 1992.- Vol. 57, N 1.- P. 92-96.
7. Ovesen P., Moller J., Moller N. et al. // Ibid.- P. 97-101.
8. Skaggs S. R., Crist D. M. // Horm. Res.- 1991.- Vol. 35.- P. 19-24.
9. Wilton P., Sietnieks A. et al. // International Symposium on Growth Disorders, 11-th.- Stockholm, 1991.- P. Ill - 115.
Review
For citations:
Dedov I.I. Clinical use of DNA recombinant human growth hormone. Problems of Endocrinology. 1993;39(5):65-67. (In Russ.) https://doi.org/10.14341/probl11996
Views:
4063
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
